Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
Clinical trial NCT04173338 · TERMINATED
Trial details
- NCT number
- NCT04173338
- Sponsor
- Augusta University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-23
- Primary completion
- 2022-03-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.